{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:56:25Z","timestamp":1788965785805,"version":"build-2803163510"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH NINDS","award":["R01NS102395"],"award-info":[{"award-number":["R01NS102395"]}]},{"name":"NIH NIEHS","award":["R01ES002710"],"award-info":[{"award-number":["R01ES002710"]}]},{"name":"NIH NIEHS Superfund Program","award":["P42ES004699"],"award-info":[{"award-number":["P42ES004699"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.pneurobio.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T02:51:42Z","timestamp":1542163902000},"page":"23-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders"],"prefix":"10.1016","volume":"172","author":[{"given":"Sydney","family":"Zarriello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P.","family":"Tuazon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Schimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Rajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Incontri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar V.","family":"Borlongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090953","article-title":"Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury","volume":"9","author":"Acosta","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pneurobio.2018.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jcp.24830","article-title":"Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson\u2019s disease","volume":"230","author":"Acosta","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.pneurobio.2018.11.001_bib0015","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/STROKEAHA.115.009854","article-title":"Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in Stroke","volume":"46","author":"Acosta","year":"2015","journal-title":"Stroke."},{"issue":"7","key":"10.1016\/j.pneurobio.2018.11.001_bib0020","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1161\/STROKEAHA.110.612358","article-title":"Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years","volume":"42","author":"Adeoye","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.wneu.2017.06.137","article-title":"Tissue expressions of soluble human epoxide Hydrolase-2 enzyme in patients with temporal lobe epilepsy","volume":"106","author":"Ahmedov","year":"2017","journal-title":"World Neurosurg."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0030","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/01.STR.0000016332.37292.59","article-title":"Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack","volume":"33","author":"Alkayed","year":"2002","journal-title":"Stroke"},{"issue":"43","key":"10.1016\/j.pneurobio.2018.11.001_bib0035","doi-asserted-by":"crossref","first-page":"32720","DOI":"10.1074\/jbc.M110.118406","article-title":"Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids","volume":"285","author":"Arnold","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.pneurobio.2018.11.001_bib0040","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/19336896.2016.1152437","article-title":"A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease","volume":"10","author":"Beckman","year":"2016","journal-title":"Prion"},{"issue":"10","key":"10.1016\/j.pneurobio.2018.11.001_bib0050","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke Statistics-2017 update: a report from the american heart association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2009.07.060","article-title":"Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase","volume":"1291","author":"Bianco","year":"2009","journal-title":"Brain Res."},{"issue":"15-16","key":"10.1016\/j.pneurobio.2018.11.001_bib0060","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1089\/ten.tea.2012.0745","article-title":"Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model","volume":"19","author":"Blais","year":"2013","journal-title":"Tissue Eng. Part A"},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3727\/096368909X479839","article-title":"Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat","volume":"19","author":"Blandini","year":"2010","journal-title":"Cell Transplant."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0070","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3389\/fphys.2018.00900","article-title":"The gut-brain Axis, the human gut microbiota and their integration in the development of obesity","volume":"9","author":"Bliss","year":"2018","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.pneurobio.2018.11.001_bib0075","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.26363","article-title":"Nonpharmacological treatments for patients with Parkinson\u2019s disease","volume":"30","author":"Bloem","year":"2015","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0080","first-page":"325","article-title":"Inadvertent extra-arachnoid (subdural) injection of a local anaesthetic agent during epidural anaesthesia. A case report","volume":"81","author":"Boezaart","year":"1992","journal-title":"S. Afr. Med. J."},{"issue":"25","key":"10.1016\/j.pneurobio.2018.11.001_bib0085","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1073\/pnas.1807276115","article-title":"Fatty acid chemical mediator provides insights into the pathology and treatment of Parkinson\u2019s disease","volume":"115","author":"Borlongan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.pneurobio.2018.11.001_bib0090","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.STR.0000141680.49960.d7","article-title":"Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke","volume":"35","author":"Borlongan","year":"2004","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","article-title":"Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase","volume":"41","author":"Capdevila","year":"2000","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0100","first-page":"843","article-title":"Inhibitors of leukotrienes synthesis: novel agents and their implementation","volume":"73","author":"Cegielska-Perun","year":"2016","journal-title":"Acta Pol. Pharm."},{"issue":"7","key":"10.1016\/j.pneurobio.2018.11.001_bib0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrneurol.2012.98","article-title":"The immunology of acute stroke","volume":"8","author":"Chamorro","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0110","first-page":"S87","article-title":"Parkinson\u2019s disease: health-related quality of life, economic cost, and implications of early treatment","volume":"16","author":"Chen","year":"2010","journal-title":"Am. J. Manag. Care"},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0115","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.RES.0000063425.51108.8D","article-title":"Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats","volume":"92","author":"Chen","year":"2003","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0091270010397049","article-title":"Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects","volume":"52","author":"Chen","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1089\/ten.teb.2012.0672","article-title":"The key regulatory roles of the PI3K\/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration","volume":"19","author":"Chen","year":"2013","journal-title":"Tissue Eng. Part B Rev."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-018-1153-1","article-title":"Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice","volume":"15","author":"Cheng","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FJC.0b013e3181506445","article-title":"The soluble epoxide hydrolase as a pharmaceutical target for hypertension","volume":"50","author":"Chiamvimonvat","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.pneurobio.2018.11.001_bib0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijpharm.2009.01.026","article-title":"An interesting relationship between drug absorption and melting point","volume":"373","author":"Chu","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/01.STR.14.4.605","article-title":"Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke-prone rats (SHRSP) and Wistar Kyoto (WKY) rats","volume":"14","author":"Coyle","year":"1983","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1586\/ern.13.54","article-title":"Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation","volume":"13","author":"D\u2019Ambrosio","year":"2013","journal-title":"Expert Rev. Neurother."},{"issue":"10","key":"10.1016\/j.pneurobio.2018.11.001_bib0155","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jacc.2010.09.070","article-title":"Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies","volume":"57","author":"D\u2019Elia","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2017.05.004","article-title":"Cytochrome P450 eicosanoids in cerebrovascular function and disease","volume":"179","author":"Davis","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0165","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/oby.2009.227","article-title":"Expression and regulation of soluble epoxide hydrolase in adipose tissue","volume":"18","author":"De Taeye","year":"2010","journal-title":"Obesity (Silver Spring)."},{"issue":"7","key":"10.1016\/j.pneurobio.2018.11.001_bib0170","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.numecd.2010.10.017","article-title":"Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in obese mice","volume":"22","author":"do Carmo","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0175","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.fjc.0000189600.74157.6d","article-title":"An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats","volume":"46","author":"Dorrance","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0180","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.biochi.2013.06.020","article-title":"The stem cell secretome and its role in brain repair","volume":"95","author":"Drago","year":"2013","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/toxsci\/50.1.30","article-title":"Soluble epoxide hydrolase in rat inflammatory cells is indistinguishable from soluble epoxide hydrolase in rat liver","volume":"50","author":"Draper","year":"1999","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/toxsci\/52.1.26","article-title":"Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals","volume":"52","author":"Draper","year":"1999","journal-title":"Toxicol. Sci."},{"issue":"1-2","key":"10.1016\/j.pneurobio.2018.11.001_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-5728(03)00134-6","article-title":"An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis","volume":"139","author":"Emsley","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"18","key":"10.1016\/j.pneurobio.2018.11.001_bib0200","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1074\/jbc.M011761200","article-title":"Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition","volume":"276","author":"Fang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0205","doi-asserted-by":"crossref","first-page":"H2412","DOI":"10.1152\/ajpheart.00527.2004","article-title":"Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels","volume":"287","author":"Fang","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3233\/JAD-180365","article-title":"Alzheimer\u2019s Disease Neuroimaging I. Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer\u2019s Disease Trajectory?","volume":"64","author":"Femminella","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"19","key":"10.1016\/j.pneurobio.2018.11.001_bib0215","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1093\/hmg\/ddi315","article-title":"The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke","volume":"14","author":"Fornage","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"25","key":"10.1016\/j.pneurobio.2018.11.001_bib0220","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1073\/pnas.1206493109","article-title":"Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols","volume":"109","author":"Fromel","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0225","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/jmf.2014.7000","article-title":"The gut microbiome and the brain","volume":"17","author":"Galland","year":"2014","journal-title":"J. Med. Food"},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/dom.12124","article-title":"Diabetes and cancer: two diseases with obesity as a common risk factor","volume":"16","author":"Garg","year":"2014","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0235","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0006-291X(79)91872-2","article-title":"Hydration of cis- and trans-epoxymethyl stearates by the cytosolic epoxide hydrase of mouse liver","volume":"89","author":"Gill","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0240","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-2952(80)90518-3","article-title":"Distribution and properties of a mammalian soluble epoxide hydrase","volume":"29","author":"Gill","year":"1980","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0245","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/jf60193a058","article-title":"Mammalian metabolism and environmental degradation of the juvenoid 1-(4\u2019-ethylphenoxy)-3,7-dimethyl-6,7-epoxy-trans-2-octene and related compounds","volume":"22","author":"Gill","year":"1974","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0250","series-title":"A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers","author":"GlaxoSmithKline","year":"2014"},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0255","series-title":"A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects","author":"GlaxoSmithKline","year":"2014"},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.taap.2015.10.018","article-title":"Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE(2) induced pain model","volume":"289","author":"Goswami","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"23","key":"10.1016\/j.pneurobio.2018.11.001_bib0265","doi-asserted-by":"crossref","first-page":"17628","DOI":"10.1016\/S0021-9258(19)85378-4","article-title":"Molecular cloning and expression of murine liver soluble epoxide hydrolase","volume":"268","author":"Grant","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0270","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00008571-199404000-00003","article-title":"Chromosomal mapping and expression levels of a mouse soluble epoxide hydrolase gene","volume":"4","author":"Grant","year":"1994","journal-title":"Pharmacogenetics"},{"issue":"10","key":"10.1016\/j.pneurobio.2018.11.001_bib0275","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00018-013-1282-8","article-title":"Vascular endothelial growth factors (VEGFs) and stroke","volume":"70","author":"Greenberg","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0280","doi-asserted-by":"crossref","first-page":"H2838","DOI":"10.1152\/ajpheart.00186.2008","article-title":"Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart","volume":"294","author":"Gross","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0285","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/jcmm.13412","article-title":"TPPU enhanced exercise-induced epoxyeicosatrienoic acid concentrations to exert cardioprotection in mice after myocardial infarction","volume":"22","author":"Guo","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.pneurobio.2018.11.001_bib0290","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/ATVBAHA.112.251520","article-title":"Soluble epoxide hydrolase: sex differences and role in endothelial cell survival","volume":"32","author":"Gupta","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0295","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0305-0491(76)90045-6","article-title":"Soluble mammalian epoxide hydratase: action on juvenile hormone and other terpenoid epoxides","volume":"53","author":"Hammock","year":"1976","journal-title":"Comp. Biochem. Physiol. B."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gene.2013.05.008","article-title":"Soluble epoxide hydrolase: gene structure, expression and deletion","volume":"526","author":"Harris","year":"2013","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1751-7133.2008.08430.x","article-title":"The potential of soluble epoxide hydrolase inhibition in the treatment of cardiac hypertrophy","volume":"14","author":"Harris","year":"2008","journal-title":"Congest. Heart Fail."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0310","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.taap.2015.03.022","article-title":"Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice","volume":"286","author":"Harris","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.pneurobio.2018.11.001_bib0315","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/0006-2952(82)90408-7","article-title":"Spectrophotometric assay for mammalian cytosolic epoxide hydrolase using trans-stilbene oxide as the substrate","volume":"31","author":"Hasegawa","year":"1982","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.pneurobio.2018.11.001_bib0320","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/14728222.2016.1226284","article-title":"Soluble epoxide hydrolase: a new therapeutic target for depression","volume":"20","author":"Hashimoto","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0325","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11682-015-9399-z","article-title":"Traumatic brain injury in the US military: epidemiology and key clinical and research programs","volume":"9","author":"Helmick","year":"2015","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0330","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.psychres.2017.02.056","article-title":"Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: an exploratory study","volume":"252","author":"Hennebelle","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.prostaglandins.2016.05.004","article-title":"EETs\/sEH in diabetes and obesity-induced cardiovascular diseases","volume":"125","author":"Huang","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0340","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbi.2014.07.016","article-title":"Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy","volume":"43","author":"Hung","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"61","key":"10.1016\/j.pneurobio.2018.11.001_bib0345","doi-asserted-by":"crossref","first-page":"103236","DOI":"10.18632\/oncotarget.21139","article-title":"Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury","volume":"8","author":"Hung","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.pneurobio.2018.11.001_bib0350","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1021\/jm2001376","article-title":"Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase","volume":"54","author":"Hwang","year":"2011","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0355","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/14796708.4.2.179","article-title":"Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent","volume":"4","author":"Iliff","year":"2009","journal-title":"Future Neurol."},{"issue":"5","key":"10.1016\/j.pneurobio.2018.11.001_bib0360","doi-asserted-by":"crossref","first-page":"H1352","DOI":"10.1152\/ajpheart.00950.2008","article-title":"Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels","volume":"296","author":"Iliff","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3-4","key":"10.1016\/j.pneurobio.2018.11.001_bib0365","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2009.06.004","article-title":"Epoxyeicosanoid signaling in CNS function and disease","volume":"91","author":"Iliff","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"10","key":"10.1016\/j.pneurobio.2018.11.001_bib0370","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2 Pt 2","key":"10.1016\/j.pneurobio.2018.11.001_bib0375","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/hy0202.103788","article-title":"Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension","volume":"39","author":"Imig","year":"2002","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0380","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1258\/ebm.2012.012225","article-title":"Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor gamma agonist improve vascular function and decrease renal injury in hypertensive obese rats","volume":"237","author":"Imig","year":"2012","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0385","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1073\/pnas.1101073108","article-title":"Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP","volume":"108","author":"Inceoglu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080922","article-title":"Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures","volume":"8","author":"Inceoglu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0395","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.HYP.0000153792.29478.1d","article-title":"Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension","volume":"45","author":"Jung","year":"2005","journal-title":"Hypertension"},{"issue":"9996","key":"10.1016\/j.pneurobio.2018.11.001_bib0400","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0405","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/0974-2700.83871","article-title":"Management of penetrating brain injury","volume":"4","author":"Kazim","year":"2011","journal-title":"J. Emerg. Trauma Shock"},{"issue":"8","key":"10.1016\/j.pneurobio.2018.11.001_bib0410","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1021\/jm030514j","article-title":"Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility","volume":"47","author":"Kim","year":"2004","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0415","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bmc.2006.09.057","article-title":"Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase","volume":"15","author":"Kim","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0420","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1089\/scd.2010.0098","article-title":"Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma","volume":"19","author":"Kim","year":"2010","journal-title":"Stem Cells Dev."},{"issue":"8","key":"10.1016\/j.pneurobio.2018.11.001_bib0425","doi-asserted-by":"crossref","first-page":"F971","DOI":"10.1152\/ajprenal.00256.2014","article-title":"Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation","volume":"307","author":"Kim","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117438","article-title":"Potent natural soluble epoxide hydrolase inhibitors from Pentadiplandra brazzeana baillon: synthesis, quantification, and measurement of biological activities in vitro and in vivo","volume":"10","author":"Kitamura","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0435","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.2741\/2889","article-title":"Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia","volume":"13","author":"Koerner","year":"2008","journal-title":"Front Biosci."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0440","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mehy.2016.06.003","article-title":"Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders","volume":"93","author":"Lakkappa","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0445","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jpba.2017.11.043","article-title":"Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS\/MS method development","volume":"149","author":"Lakkappa","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.pneurobio.2018.11.001_bib0450","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bcp.12855","article-title":"Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor","volume":"81","author":"Lazaar","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0455","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fcell.2017.00051","article-title":"Stem cell-induced biobridges as possible tools to aid neuroreconstruction after CNS injury","volume":"5","author":"Lee","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"7561","key":"10.1016\/j.pneurobio.2018.11.001_bib0460","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature14569","article-title":"Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment","volume":"523","author":"Li","year":"2015","journal-title":"Nature."},{"issue":"Pt A","key":"10.1016\/j.pneurobio.2018.11.001_bib0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pnpbp.2017.03.021","article-title":"Harnessing neural stem cells for treating psychiatric symptoms associated with fetal alcohol spectrum disorder and epilepsy","volume":"80","author":"Lippert","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"46","key":"10.1016\/j.pneurobio.2018.11.001_bib0470","doi-asserted-by":"crossref","first-page":"16747","DOI":"10.1073\/pnas.0508081102","article-title":"The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase","volume":"102","author":"Liu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0475","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1476-5381.2008.00009.x","article-title":"Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation","volume":"156","author":"Liu","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0480","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.10.025","article-title":"Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model","volume":"79","author":"Liu","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"4-5","key":"10.1016\/j.pneurobio.2018.11.001_bib0485","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejps.2012.12.013","article-title":"Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models","volume":"48","author":"Liu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0490","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12031-015-0670-y","article-title":"Epoxyeicosanoid signaling provides multi-target protective effects on neurovascular unit in rats after focal ischemia","volume":"58","author":"Liu","year":"2016","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0495","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1073\/pnas.1422590112","article-title":"Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides","volume":"112","author":"Lopez-Vicario","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0500","first-page":"97","article-title":"Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities","volume":"11","author":"Lozano","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0505","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-018-0900-8","article-title":"Herp promotes degradation of mutant huntingtin: involvement of the proteasome and molecular chaperones","author":"Luo","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"8695","key":"10.1016\/j.pneurobio.2018.11.001_bib0510","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/0140-6736(90)91006-V","article-title":"Parkinson\u2019s disease","volume":"335","author":"Marsden","year":"1990","journal-title":"Lancet"},{"issue":"52","key":"10.1016\/j.pneurobio.2018.11.001_bib0515","doi-asserted-by":"crossref","first-page":"35826","DOI":"10.1074\/jbc.M114.588087","article-title":"Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7","volume":"289","author":"Matsumoto","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.pneurobio.2018.11.001_bib0520","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2165\/11634020-000000000-00000","article-title":"A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury","volume":"26","author":"McConeghy","year":"2012","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0525","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresrev.2006.11.003","article-title":"Molecular targets in cerebral ischemia for developing novel therapeutics","volume":"54","author":"Mehta","year":"2007","journal-title":"Brain Res. Rev."},{"issue":"8","key":"10.1016\/j.pneurobio.2018.11.001_bib0530","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1021\/acs.accounts.5b00226","article-title":"Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation","volume":"48","author":"Meng","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0535","doi-asserted-by":"crossref","first-page":"384342","DOI":"10.1155\/2014\/384342","article-title":"Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage","volume":"2014","author":"Miller","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.pneurobio.2018.11.001_bib0540","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1165\/rcmb.2009-0155OC","article-title":"17,18-epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase","volume":"43","author":"Morin","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0545","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.pneurobio.2018.11.001_bib0550","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0006-2952(02)00952-8","article-title":"Structural refinement of inhibitors of urea-based soluble epoxide hydrolases","volume":"63","author":"Morisseau","year":"2002","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0555","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.M006007","article-title":"Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids","volume":"51","author":"Morisseau","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0560","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neuropharm.2017.05.013","article-title":"11,12 -Epoxyeicosatrienoic acid (11,12 EET) reduces excitability and excitatory transmission in the hippocampus","volume":"123","author":"Mule","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0565","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0003-2697(79)90619-5","article-title":"A partition assay for epoxide hydrases acting on insect juvenile hormone and an epoxide-containing juvenoid","volume":"92","author":"Mumby","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1-3","key":"10.1016\/j.pneurobio.2018.11.001_bib0570","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0048-3575(79)90067-1","article-title":"Substrate selectivity and stereochemistry of enzymatic epoxide hydration in the soluble fraction of mouse liver","volume":"11","author":"Mumby","year":"1979","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0575","article-title":"Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and neuroprotective effects against stroke","author":"Neal","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0580","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prostaglandins.2014.09.003","article-title":"Role of soluble epoxide hydrolase in age-related vascular cognitive decline","volume":"113-115","author":"Nelson","year":"2014","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0585","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1073\/pnas.0437724100","article-title":"The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity","volume":"100","author":"Newman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"219","key":"10.1016\/j.pneurobio.2018.11.001_bib0590","first-page":"1","article-title":"Prevalence of Obesity Among Adults and Youth: United States, 2011-2014","author":"Ogden","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0595","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1124\/jpet.106.103556","article-title":"Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels","volume":"318","author":"Olearczyk","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0600","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/CS20080039","article-title":"Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats","volume":"116","author":"Olearczyk","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"issue":"8","key":"10.1016\/j.pneurobio.2018.11.001_bib0605","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1164\/rccm.201403-0544OC","article-title":"Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma","volume":"190","author":"Ono","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0610","series-title":"Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial","author":"Oregon H","year":"2018"},{"issue":"Pt A","key":"10.1016\/j.pneurobio.2018.11.001_bib0615","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.prostaglandins.2015.06.005","article-title":"Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): resulting drug levels and modulation of oxylipin pattern","volume":"121","author":"Ostermann","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"4438","key":"10.1016\/j.pneurobio.2018.11.001_bib0620","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.7361100","article-title":"Cytosolic and microsomal epoxide hydrolases: differential properties in mammalian liver","volume":"207","author":"Ota","year":"1980","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0625","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1471-4159.2008.05589.x","article-title":"Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson\u2019s disease","volume":"107","author":"Park","year":"2008","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0630","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0006-2952(95)00167-X","article-title":"Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice","volume":"50","author":"Pinot","year":"1995","journal-title":"Biochem. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.pneurobio.2018.11.001_bib0635","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000109998","article-title":"Prevalence of dementia in the United States: the aging, demographics, and memory study","volume":"29","author":"Plassman","year":"2007","journal-title":"Neuroepidemiology."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0640","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/WCO.0000000000000248","article-title":"Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury","volume":"28","author":"Prakash","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0645","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12035-014-8833-3","article-title":"Soluble epoxide hydrolase deficiency or inhibition attenuates MPTP-Induced parkinsonism","volume":"52","author":"Qin","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0650","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-5922.2010.00150.x","article-title":"Soluble epoxide hydrolase inhibitors and heart failure","volume":"29","author":"Qiu","year":"2011","journal-title":"Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-014-1456-2","article-title":"The protective effect of epoxyeicosatrienoic acids on cerebral ischemia\/reperfusion injury is associated with PI3K\/Akt pathway and ATP-sensitive potassium channels","volume":"40","author":"Qu","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0660","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/NDT.S114786","article-title":"Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms","volume":"13","author":"Rao","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"13","key":"10.1016\/j.pneurobio.2018.11.001_bib0665","doi-asserted-by":"crossref","first-page":"E1944","DOI":"10.1073\/pnas.1601532113","article-title":"Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress","volume":"113","author":"Ren","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"25","key":"10.1016\/j.pneurobio.2018.11.001_bib0670","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1802179115","article-title":"Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson\u2019s disease","volume":"115","author":"Ren","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6859","key":"10.1016\/j.pneurobio.2018.11.001_bib0675","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"issue":"5 Suppl","key":"10.1016\/j.pneurobio.2018.11.001_bib0680","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.2223\/JPED.1553","article-title":"Antileukotrienes in the treatment of asthma and allergic rhinitis","volume":"82","author":"Ribeiro","year":"2006","journal-title":"J. Pediatr. (Rio J)."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0685","doi-asserted-by":"crossref","DOI":"10.3390\/cells5020016","article-title":"The NF-kappaB pathway and Cancer stem cells","volume":"5","author":"Rinkenbaugh","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0690","series-title":"Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects","article-title":"Stem cell therapy in brain trauma: implications for repair and regeneration of injured brain in experimental TBI models","author":"Rolfe","year":"2015"},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0695","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2011.07.058","article-title":"Differential effect of amyloid beta on the cytochrome P450 epoxygenase activity in rat brain","volume":"194","author":"Sarkar","year":"2011","journal-title":"Neuroscience"},{"issue":"28","key":"10.1016\/j.pneurobio.2018.11.001_bib0700","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.0503279102","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","volume":"102","author":"Schmelzer","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"37","key":"10.1016\/j.pneurobio.2018.11.001_bib0705","doi-asserted-by":"crossref","first-page":"13646","DOI":"10.1073\/pnas.0605908103","article-title":"Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors","volume":"103","author":"Schmelzer","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0710","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/aje\/kwn068","article-title":"Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder","volume":"167","author":"Schneiderman","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0715","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1096\/fj.04-3128fje","article-title":"Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat","volume":"19","author":"Sellers","year":"2005","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0720","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.RES.0000237390.92932.37","article-title":"Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function","volume":"99","author":"Seubert","year":"2006","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.pneurobio.2018.11.001_bib0725","doi-asserted-by":"crossref","first-page":"H1605","DOI":"10.1152\/ajpheart.00471.2013","article-title":"Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke","volume":"305","author":"Shaik","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.pneurobio.2018.11.001_bib0730","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1517\/13543776.2010.484804","article-title":"Soluble epoxide hydrolase inhibitors: a patent review","volume":"20","author":"Shen","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.pneurobio.2018.11.001_bib0735","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/jm201468j","article-title":"Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications","volume":"55","author":"Shen","year":"2012","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0740","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/HTR.0b013e3182571c14","article-title":"Prevalence of traumatic brain injury in an offender population: a meta-analysis","volume":"27","author":"Shiroma","year":"2012","journal-title":"J. Head Trauma Rehabil."},{"issue":"7","key":"10.1016\/j.pneurobio.2018.11.001_bib0745","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/STROKEAHA.114.008560","article-title":"Soluble epoxide hydrolase in hydrocephalus, cerebral edema, and vascular inflammation after subarachnoid hemorrhage","volume":"46","author":"Siler","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0750","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12028-014-0011-y","article-title":"Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage","volume":"22","author":"Siler","year":"2015","journal-title":"Neurocrit. Care"},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0755","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2353\/ajpath.2009.080544","article-title":"Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection","volume":"174","author":"Simpkins","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"14","key":"10.1016\/j.pneurobio.2018.11.001_bib0760","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.1221972110","article-title":"Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis","volume":"110","author":"Sirish","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0765","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Prog. Lipid Res."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0770","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0775","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pneurobio.2017.07.004","article-title":"Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms","volume":"158","author":"Stonesifer","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0780","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.prostaglandins.2012.07.005","article-title":"Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury","volume":"104-105","author":"Strauss","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"7","key":"10.1016\/j.pneurobio.2018.11.001_bib0785","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1517\/14712598.2015.1043264","article-title":"A possible new focus for stroke treatment - migrating stem cells","volume":"15","author":"Sullivan","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.pneurobio.2018.11.001_bib0790","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1369\/jhc.2008.950659","article-title":"Distribution and expression of soluble epoxide hydrolase in human brain","volume":"56","author":"Sura","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0795","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2018.01.010","article-title":"Metabolic\/inflammatory\/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target","volume":"87","author":"Swardfager","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.pneurobio.2018.11.001_bib0800","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/brain\/awx195","article-title":"Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy","volume":"140","author":"Syrbe","year":"2017","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0805","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/brain\/awx350","article-title":"Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model","volume":"141","author":"Tagge","year":"2018","journal-title":"Brain"},{"issue":"Pt 6","key":"10.1016\/j.pneurobio.2018.11.001_bib0810","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1042\/BST0331522","article-title":"Role of the phosphoinositide 3-kinase pathway in mouse embryonic stem (ES) cells","volume":"33","author":"Takahashi","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0815","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2016.05.046","article-title":"Correlations of platelet-leukocyte aggregates with P-selectin S290N and P-selectin glycoprotein ligand-1 M62I genetic polymorphisms in patients with acute ischemic stroke","volume":"367","author":"Tao","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.pneurobio.2018.11.001_bib0820","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5922.2011.00282.x","article-title":"Evaluation of the effects of urotensin II and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients","volume":"30","author":"Tran","year":"2012","journal-title":"Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0825","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1038\/s41598-018-23504-1","article-title":"Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia","volume":"8","author":"Tu","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0830","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/FJC.0b013e318298e460","article-title":"Anti-inflammatory effects of omega-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension","volume":"62","author":"Ulu","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0835","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0495.1000300","article-title":"Inhibition of soluble epoxide hydrolase as a novel approach to high dose diazepam induced hypotension","volume":"6","author":"Ulu","year":"2016","journal-title":"J. Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0840","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12015-013-9486-8","article-title":"Wnt signaling and the control of human stem cell fate","volume":"10","author":"Van Camp","year":"2014","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0845","series-title":"Soluble Epoxide Hydrolase Inhibition and Insulin Resistance","author":"Vanderbilt University Medical C","year":"2018"},{"issue":"25","key":"10.1016\/j.pneurobio.2018.11.001_bib0850","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New Biol."},{"issue":"1-4","key":"10.1016\/j.pneurobio.2018.11.001_bib0855","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prostaglandins.2011.07.005","article-title":"Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes","volume":"96","author":"Vanella","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0860","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani","year":"2013","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pneurobio.2018.11.001_bib0865","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.taap.2014.10.001","article-title":"Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication","volume":"281","author":"Vito","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0870","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","article-title":"Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases","volume":"180","author":"Wagner","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0875","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/acs.jcim.5b00592","article-title":"Discovery of potent soluble epoxide hydrolase (sEH) inhibitors by pharmacophore-based virtual screening","volume":"56","author":"Waltenberger","year":"2016","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0880","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.HYP.0000090123.55365.BA","article-title":"Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension","volume":"42","author":"Wang","year":"2003","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.pneurobio.2018.11.001_bib0885","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1073\/pnas.1721711115","article-title":"Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0890","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/jnr.24080","article-title":"The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice","volume":"95","author":"Wu","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0895","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ijcard.2012.03.167","article-title":"A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARgamma to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction","volume":"167","author":"Xu","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0900","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bcp.12603","article-title":"The role of epoxyeicosatrienoic acids in the cardiovascular system","volume":"80","author":"Yang","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0905","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1165\/rcmb.2013-0440OC","article-title":"Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice","volume":"52","author":"Yang","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.pneurobio.2018.11.001_bib0910","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.chest.2016.10.058","article-title":"Mechanisms of vascular dysfunction in COPD and effects of a novel soluble epoxide hydrolase inhibitor in smokers","volume":"151","author":"Yang","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0915","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jnutbio.2017.07.006","article-title":"Postprandial effect to decrease soluble epoxide hydrolase activity: roles of insulin and gut microbiota","volume":"49","author":"Yang","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"11","key":"10.1016\/j.pneurobio.2018.11.001_bib0920","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.pneurobio.2018.11.001_bib0925","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.jcbfm.9600494","article-title":"Soluble epoxide hydrolase: a novel therapeutic target in stroke","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.pneurobio.2018.11.001_bib0930","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/FPC.0b013e3282f313e8","article-title":"Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population","volume":"18","author":"Zhang","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"issue":"7","key":"10.1016\/j.pneurobio.2018.11.001_bib0935","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/STROKEAHA.107.508325","article-title":"Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia","volume":"39","author":"Zhang","year":"2008","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.pneurobio.2018.11.001_bib0940","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/jcbfm.2009.65","article-title":"Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia","volume":"29","author":"Zhang","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.pneurobio.2018.11.001_bib0945","article-title":"Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.pneurobio.2018.11.001_bib0950","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1073\/pnas.1304321110","article-title":"Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"30","key":"10.1016\/j.pneurobio.2018.11.001_bib0955","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1073\/pnas.1410432111","article-title":"Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0960","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.plipres.2013.11.003","article-title":"Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer","volume":"53","author":"Zhang","year":"2014","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.pneurobio.2018.11.001_bib0965","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/jnc.13933","article-title":"Inhibition of soluble epoxide hydrolase augments astrocyte release of vascular endothelial growth factor and neuronal recovery after oxygen-glucose deprivation","volume":"140","author":"Zhang","year":"2017","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.pneurobio.2018.11.001_bib0970","first-page":"1244","article-title":"Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage","volume":"15","author":"Zhao","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0975","first-page":"290","article-title":"Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice","volume":"5","author":"Zuloaga","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pneurobio.2018.11.001_bib0980","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/7854_2012_211","article-title":"Inflammation and depression","volume":"14","author":"Zunszain","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008218301254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008218301254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:58:29Z","timestamp":1759550309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008218301254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":196,"alternative-id":["S0301008218301254"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2018.11.001","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}